An Update from the FDA on Social Media Guidance

Posted by: in Advertising, Communication Strategy, Digital Health, Healthcare Insights, Medical Communications, Social Media Insights & Trends on January 15, 2014

It’s been a long time coming, but it looks like the FDA is getting around to providing guidance to the healthcare industry around social media. Granted that realtime online conversations and the heavily regulated drug industry aren’t the most obvious of bedfellows, but it’s a reality and it’s here to stay.

It looks like the FDA is taking a stand (sort of), having recently released draft guidelines for regulated healthcare companies on what they call Interactive Promotional Media (pdf) . While not a comprehensive document about managing all social media content and channels, it is an important start on the road to clarity and the most direct guidance that the FDA has issued on the topic so far. Read more on the blog  at Twist (our sister company at W2O Group) where colleague, Colin Foster, breaks it down.

By: Aaron Strout

Aaron is the President of WCG, one of the three agencies under the W2O Group umbrella. He is a regular contributor to Marketing Land and a co-host of video podcast, Live from Stubbs.

Find me on: Twitter Facebook
Pre-Commerce Check out W2O Group President Bob Pearson's new book, Pre-Commerce, in which he shares ideas for leaders to engage directly with customers to shape their brand and marketplace success. Now available for order on Amazon.com! http://amzn.to/bAmvFN. Join the conversation #precommerce.

One Response

Stay in touch with the conversation, subscribe to the RSS feed for comments on this post.

Continuing the Discussion

  1. The Week in Social Analytics #85 at TweetReach Blog linked to this post on January 17, 2014

    […] Update from the FDA on Social Media Guidance [from Common Sense; written by Aaron Strout] “It’s been a long time coming, but it looks like the FDA is getting around to providing guidance to the healthcare industry around social media. Granted that realtime online conversations and the heavily regulated drug industry aren’t the most obvious of bedfellows, but it’s a reality and it’s here to stay.” […]

Some HTML is OK

(required)

(required, but never shared)

or, reply to this post via trackback.